Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126093822 | 12609382 | 2 | F | 20160708 | 20160818 | 20160801 | 20160819 | EXP | FR-ROCHE-1804118 | ROCHE | 60.00 | YR | M | Y | 0.00000 | 20160819 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126093822 | 12609382 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
| 126093822 | 12609382 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | 780 | MG | SOLUTION FOR INFUSION | /cycle | ||||||
| 126093822 | 12609382 | 3 | SS | IFOSFAMIDE EG | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | U | 0 | 10400 | MG | /cycle | |||||||
| 126093822 | 12609382 | 4 | SS | ETOPOSIDE MYLAN | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | U | 0 | 200 | MG | ||||||||
| 126093822 | 12609382 | 5 | SS | CARBOPLATIN HOSPIRA | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | U | 0 | 790 | MG | /cycle | |||||||
| 126093822 | 12609382 | 6 | C | FLUDARABINE | FLUDARABINE PHOSPHATE | 1 | 0 | ||||||||||||
| 126093822 | 12609382 | 7 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 126093822 | 12609382 | 8 | C | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126093822 | 12609382 | 9 | C | VINCRISTINE | VINCRISTINE | 1 | 0 | ||||||||||||
| 126093822 | 12609382 | 10 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126093822 | 12609382 | 1 | Lymphoma |
| 126093822 | 12609382 | 3 | Lymphoma |
| 126093822 | 12609382 | 4 | Lymphoma |
| 126093822 | 12609382 | 5 | Lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126093822 | 12609382 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126093822 | 12609382 | Encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126093822 | 12609382 | 2 | 20160706 | 20160706 | 0 | |
| 126093822 | 12609382 | 3 | 20160706 | 20160706 | 0 | |
| 126093822 | 12609382 | 4 | 20160706 | 20160706 | 0 | |
| 126093822 | 12609382 | 5 | 20160706 | 20160706 | 0 |